Ibaraki, Japan

Haruhisa Yoshikawa

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sysmex Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruhisa Yoshikawa. Retrieved from https://idiyas.com/inventor/haruhisa-yoshikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruhisa Yoshikawa: Innovator in Artificial Nucleic Acids

Introduction

Haruhisa Yoshikawa is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of artificial nucleic acids. His work has implications for various applications in medicine and research.

Latest Patents

Yoshikawa holds a patent for an artificial nucleic acid, along with its production method and uses. This patent is a testament to his innovative approach in creating compounds that can potentially revolutionize genetic research and therapeutic applications.

Career Highlights

Yoshikawa is associated with Sysmex Corporation, where he has been instrumental in advancing the company's research initiatives. His expertise in nucleic acid technology has positioned him as a key figure in the biotechnology sector.

Collaborations

He has collaborated with notable colleagues, including Ikuya Ban and Ayako Orita, to further enhance the research and development of nucleic acid technologies.

Conclusion

Haruhisa Yoshikawa's contributions to the field of artificial nucleic acids highlight his innovative spirit and dedication to advancing biotechnology. His work continues to inspire future research and development in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…